Boosting endocannabinoid levels disrupted habit formation in mice

Inhibiting the enzymes that break down endocannabinoids (FAAH and MAGL) disrupted habitual behavior formation in mice, suggesting the endocannabinoid system plays a nuanced role in how behaviors become automatic.

Gianessi, Carol A et al.·The European journal of neuroscience·2022·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-03868Animal StudyPreliminary Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Both FAAH inhibition (increasing anandamide) and MAGL inhibition (increasing 2-AG) disrupted habit formation during operant training in mice. This was unexpected, as previous work showed that blocking CB1 receptors also disrupted habits, suggesting that both too much and too little endocannabinoid signaling can impair habit formation.

Key Numbers

Both FAAH and MAGL inhibitors disrupted habit formation. AM251 also disrupted habits but showed vehicle-dependent dose-response inconsistencies, raising methodological concerns about prior studies.

How They Did This

Pharmacological study using selective FAAH and MAGL inhibitors during food-reinforced operant training in mice. Habit assessed using contingency degradation. Also tested CB1 antagonist AM251 in solution vs suspension formulations.

Why This Research Matters

Habit formation is central to substance use disorders. Understanding how endocannabinoids regulate habit formation could lead to interventions that prevent the automatic drug-seeking behaviors that drive addiction.

The Bigger Picture

The finding that augmenting endocannabinoids may prevent aberrant habit formation has potential clinical applications for preventing the compulsive behaviors seen in substance use disorders.

What This Study Doesn't Tell Us

Mouse model with food reward; habit formation for drugs may differ. Methodological concerns about AM251 vehicle formulations complicate interpretation of prior literature. FAAH inhibitors affect multiple lipid mediators beyond anandamide.

Questions This Raises

  • ?Could endocannabinoid-augmenting drugs prevent the transition from voluntary to compulsive drug use?
  • ?Is there an optimal level of endocannabinoid signaling for healthy habit formation?

Trust & Context

Key Stat:
Both FAAH and MAGL inhibition disrupted habit formation
Evidence Grade:
Well-designed behavioral pharmacology study, but mouse food-reward paradigm may not translate to human drug-seeking habits.
Study Age:
Published in 2022.
Original Title:
The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice.
Published In:
The European journal of neuroscience, 55(4), 922-938 (2022)
Database ID:
RTHC-03868

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

How could this relate to addiction?

Addiction involves the transition from voluntary, goal-directed drug use to automatic, habitual drug seeking. If endocannabinoid-boosting drugs can prevent habit formation, they could potentially prevent this transition.

Isn't blocking CB1 and boosting endocannabinoids opposite approaches?

Yes, and that's the surprising finding. Both blocking CB1 (reducing signaling) and boosting endocannabinoids (increasing signaling) disrupted habits, suggesting the system needs to be in a specific balance for habits to form.

Read More on RethinkTHC

Cite This Study

RTHC-03868·https://rethinkthc.com/research/RTHC-03868

APA

Gianessi, Carol A; Groman, Stephanie M; Taylor, Jane R. (2022). The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice.. The European journal of neuroscience, 55(4), 922-938. https://doi.org/10.1111/ejn.15129

MLA

Gianessi, Carol A, et al. "The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice.." The European journal of neuroscience, 2022. https://doi.org/10.1111/ejn.15129

RethinkTHC

RethinkTHC Research Database. "The effects of fatty acid amide hydrolase inhibition and mon..." RTHC-03868. Retrieved from https://rethinkthc.com/research/gianessi-2022-the-effects-of-fatty

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.